Right to FDA-Approved Medicines Act (H.R. 4525)
Referred to CommitteeLatest Action
Referred to the House Committee on Energy and Commerce.
7/17/2025 • House
Summary
Right to FDA-Approved Medicines Act
This bill sets out statutory protections for an individual's right to access and a health care provider's right to provide medicines (i.e., drugs and biological products) approved by the Food and Drug Administration (FDA).
Generally, the bill prohibits measures that single out and impede access to FDA-approved medicines and related information. However, a party may defend against a claim that a measure violates the bill's prohibitions by demonstrating, through clear and convincing evidence, that the measure significantly advances access to FDA-approved medicines and such access cannot be advanced through less restrictive means. The bill also specifies that the prohibition preempts inconsistent state and local laws and applies in spite of other federal laws, including the Religious Freedom Restoration Act of 1993.
The Department of Justice, individuals, or health care providers may bring a lawsuit to enforce this bill, and states are not immune from suits for violations.
Introduced in House • 7/17/2025
Topics & Subjects
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (30)
Party Breakdown
Sponsor
Cosponsors (29)
Bill Journey
Originated in the House
Introduced
July 17, 2025
Referred to the House Committee on Energy and Commerce.
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law
Text Versions (1)
Details
Sources and method
· Congress.gov, CRS, USAspending, FEC, LDA · Record updated Oct 28, 2026
- Congress.govLibrary of CongressStatus, actions, sponsors, cosponsors, committees and textRecord updated Oct 28, 2026 · Loaded Oct 28, 2026, 5:21 PM ET
- CRS bill summaryCongressional Research Service, via Congress.govOfficial summarySummary of the “Introduced in House” version, Jul 17, 2025 · Loaded Oct 28, 2026, 5:21 PM ET
- USAspending.govU.S. Department of the TreasuryRelated Federal Spending section
- FEC filingsFederal Election CommissionFunding & Lobbying section
- Lobbying disclosures (LDA)Secretary of the Senate and Clerk of the HouseFunding & Lobbying section
All sources: Public domain (17 U.S.C. § 105) · Method: Data sources → · Campaign finance →
AI-written text on this page is labeled where it appears. It is written from the sources above and is not a source itself. How we analyze data →
Dates shown where the source reports one. “Loaded” is when CIV.IQ last fetched the record.